falsefalse
Advertisement

Evidence-Based Strategies for COPD Diagnosis, Management, and Prevention - Episode 5

Treatment of COPD Based on Symptoms

Published on: 
, , ,

Panelists discuss how chronic obstructive pulmonary disease (COPD) management follows a stepwise approach, beginning with bronchodilators (typically short-acting β2-agonists/long-acting β2-agonists) and progressing to combination therapy with long-acting muscarinic antagonists/inhaled corticosteroids based on symptom severity. Current unmet needs include more targeted anti-inflammatory treatments, better biomarkers for phenotyping, and therapies to halt disease progression, particularly for those who don’t respond well to conventional treatments.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Video content above is prompted by the following:

      • What is the typical treatment progression in symptomatic COPD?
      • Explain the role of inflammation and discuss the percentage of patients with COPD who have type 2 inflammation.
      • What are some of the unmet needs in the treatment of COPD?
      Advertisement
      Advertisement
      Advertisement
      x